Delivery Order SPE2DB22D9239-SPE2DB24FDL98

Award Date 8/26/24
Potential Completion Date 9/17/24
Potential Value $33K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $32,934.00 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract covers the delivery of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product. This award is part of DMS Pharmaceutical Group's larger Indefinite Delivery Contract (IDC) with the DLA valued at $499,999,999, which enables the agency to issue delivery...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract valued at $32,004.00 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the delivery of PRIVIGEN 10% VIAL 200ML pharmaceutical product. This order is part of DMS Pharmaceutical Group's broader indefinite delivery contract (IDV) with DLA under the SPE2DB program, valued at up to $4,999,999 through 2025, for the provision of a wide range of...
The U.S. Defense Logistics Agency (DLA) awarded a Delivery Order to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $38,404.80, is for the supply of PRIVIGEN 10% VIAL 200ML, a pharmaceutical product. The Delivery Order is part of a larger Indefinite Delivery Contract (IDC) vehicle, valued up to $499,999,999, that DMS Pharmaceutical Group holds with the DLA under the SPE2DB program. This single-award...
This is a firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,934 contract is for the delivery of the pharmaceutical product PRIVIGEN 10% VIAL 400ML. The contract has an ultimate completion date of November 20, 2024. DMS Pharmaceutical Group holds a $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $42,814.20 contract is for the supply of PRIVIGEN 10% vial (400 mL), a critical pharmaceutical product, to support the recurring medical needs of military healthcare facilities worldwide. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $32,934.00 contract is for the supply of PRIVIGEN 10% vial, a pharmaceutical product, with a period of performance through August 13, 2024. This award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued up to $499,999,999, which allows the DLA...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth $19,760.40 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is for the supply of PRIVIGEN 10% vial 200 mL, a specialized pharmaceutical product. This delivery order is issued under DMS Pharmaceutical Group's larger $499,999,999 Indefinite Delivery Contract (IDC) with the DLA under the SPE2DB program, which enables the...
This is a federal contract award from the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a $34,251.00 firm fixed-price delivery order for the supply of PRIVIGEN 10% VIAL 200ML, a specialized pharmaceutical product. The contract has an ultimate completion date of April 9, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery Contract (IDC) with...
This federal contract award was issued by the Defense Logistics Agency (DLA) to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The $26,347.24 firm fixed-price delivery order is for the supply of PRIVIGEN 10% VIAL 400ML, a pharmaceutical product, with a period of performance through September 19, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract (IDC) with the DLA under the SPE2DB program, valued at...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract worth up to $40,005.00 to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is for the delivery of Privigen 10% vial, a 200 ml immunoglobulin product, with a period of performance through May 22, 2024. This delivery order is part of a larger $499,999,999 indefinite delivery contract (IDC) held by DMS Pharmaceutical Group Inc. under the DLA's SPE2DB...
  • SPE2DB22D9239
    Indefinite Delivery Contract
  • SPE2DB22D9239-SPE2DB24FDL98
    Delivery Order

The U.S. Department of Defense's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $32,934.00, is for the delivery of the pharmaceutical product PRIVIGEN 10% VIAL 200ML. The contract has an ultimate completion date of September 17, 2024.

This delivery order is part of a larger, single-award indefinite delivery contract (IDC) between DMS Pharmaceutical Group and the DLA under the SPE2DB program, which has a total potential value of up to $499,999,999 and runs through December 31, 2025. The IDC allows the DLA to issue firm fixed-price delivery orders for a comprehensive range of pharmaceutical items to fulfill the recurring medical supply needs of military health facilities worldwide. Through this contract vehicle, DMS Pharmaceutical Group provides both routine and critical medications to support the diverse medical requirements of the Department of Defense's healthcare facilities and personnel.

Generated 11/25/24, 9:24 AM